FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Expires: February 28, 2011
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

WEST COAST ASSET MANAGEMENT INC

2. Date of Event Requiring Statement (MM/DD/YYYY)
2/15/2008 

3. Issuer Name and Ticker or Trading Symbol

ANGIOTECH PHARMACEUTICALS INC [ANPI]

(Last)        (First)        (Middle)

2151 ALESSANDRO DR, STE 215

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                            _____ 10% Owner
_____ Officer (give title below)          ___ X ___ Other (specify below)
/ See remarks below

(Street)

VENTURA, CA 93001       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

3/3/2008 

6. Individual or Joint/Group Filing (Check Applicable Line)

___ Form filed by One Reporting Person
_ X _ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4) 		2. Amount of Securities Beneficially Owned
(Instr. 4) 		3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5) 		4. Nature of Indirect Beneficial Ownership
(Instr. 5)

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4) 		2. Date Exercisable and Expiration Date
(MM/DD/YYYY) 		3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4) 		4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5) 		6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:

Remarks:
The Reporting Persons are filing this Form 3/A to indicate that the Form 3 previously filed on 03/03/08 (the Original Form 3) was filed in error and should be treated as if it were withdrawn. The Original Form 3 was not required to be filed because the Reporting Persons were not as of the event date of the Original Form 3, and currently are not, beneficial owners of more than 10% of a class of equity securities of the Issuer registered under Section 12 of the Securities Exchange Act of 1934, as determined in accordance with the rules promulgated thereunder.
No securities are beneficially owned.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
WEST COAST ASSET MANAGEMENT INC
2151 ALESSANDRO DR
STE 215
VENTURA, CA 93001


See remarks below
Lowe R Atticus
2151 ALESSANDRO DRIVE
SUITE 215
VENTURA, CA 93001


See remarks below
Helfert Lance W
2151 ALESSANDRO DRIVE
SUITE 215
VENTURA, CA 93001


See remarks below
Orfalea Paul J
2151 ALESSANDRO DRIVE
SUITE 215
VENTURA, CA 93001


See remarks below

Signatures
Linda Schuman as Attorney In Fact 7/8/2008
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Angiotech Pharmaceuticals - Common Shares (MM) (NASDAQ:ANPI)
Historical Stock Chart
Von Jun 2024 bis Jul 2024 Click Here for more Angiotech Pharmaceuticals - Common Shares (MM) Charts.
Angiotech Pharmaceuticals - Common Shares (MM) (NASDAQ:ANPI)
Historical Stock Chart
Von Jul 2023 bis Jul 2024 Click Here for more Angiotech Pharmaceuticals - Common Shares (MM) Charts.